Work

A Randomized, Placebo-Controlled Dose-Comparison Trial of Haloperidol for Psychosis and Disruptive Behaviors in Alzheimer’s Disease

Year: 1998

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: American Journal of Psychiatry

DOI: 10.1176/ajp.155.11.1512

Authors: D.P. Devanand, Karen Marder, Kristin S. Michaels, Harold A. Sackeim, Karen Bell, Maria A. Sullivan, Thomas B. Cooper, Gregory H. Pelton, Richard Mayeux

Institution: New York State Psychiatric Institute

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Mental Health

Awards: G2424121640, G2779682921, QUESTIONABLE DEMENTIA--COURSE AND PREDICTORS OF OUTCOME, HALOPERIDOL TREATMENT IN ALZHEIMER'S DISEASE, G550639118, TREATMENT OF BEHAVIORAL SYMPTOMS IN ALZHEIMERS DISEASE

OpenAlex ID: W1990510530

FWCI: 12.25

Cites: 55

Cited by: 236

Related to: 10